Breaking News

FDA COVID-19 Update

Issues guidance highlighting flexibility under the Drug Supply Chain Security Act

By: Contract Pharma

Contract Pharma Staff

The U.S. FDA has taken the following action as of April 30th in the ongoing response effort to the COVID-19 pandemic:  Tthe FDA included, under the ventilator emergency use authorization (EUA), a ventilator developed by the National Aeronautics and Space Administration (NASA), which is tailored to treat patients with COVID-19. The ventilator was added to the list of authorized ventilators, ventilator tubing connectors and ventilator accessories under the ventilator EUA that was issued in...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters